Clear cell sarcoma of the kidney demonstrates an embryonic signature indicative of a primitive nephrogenic origin

Genes Chromosomes and Cancer

Volumn 53, Issue 5, 2014, Pages 381-391

  Karlsson, Jenny ^a   Holmquist Mengelbier, Linda ^a   Ciornei, Cristina D ^b   Naranjo, Arlene ^c   O'Sullivan, Maureen J ^d   Gisselsson, David ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b Department of Pathology Skåne Regional and University Laboratories ^*  (Sweden)

^c UNIVERSITY OF FLORIDA   (United States)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ALLELIC IMBALANCE; ARTICLE; CELL DIFFERENTIATION; CHILDHOOD CANCER; CITED1 GENE; CLEAR CELL SARCOMA; EMBRYO DEVELOPMENT; EPITHELIUM CELL; FOXD1 GENE; GENE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENOTYPING TECHNIQUE; KIDNEY DEVELOPMENT; KIDNEY PARENCHYMA; KIDNEY SARCOMA; MESODERM; ONSET AGE; OSR1 GENE; PRIORITY JOURNAL; RNA EXTRACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; HUMANS; INFANT; KIDNEY; KIDNEY NEOPLASMS; MALE; NUCLEAR PROTEINS; PARAFFIN EMBEDDING; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOMA, CLEAR CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84895926355     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22149     Document Type: Article

References (34)

1. Argani P, Perlman EJ, Breslow NE, Browning NG, Green DM, D'Angio GJ, Beckwith JB. 2000. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol 24:4-18.
2. Barnard M, Bayani J, Grant R, Zielenska M, Squire J, Thorner P. 2000. Comparative genomic hybridization analysis of clear cell sarcoma of the kidney. Med Pediatr Oncol 34:113-116.
3. Batourina E, Gim S, Bello N, Shy M, Clagett-Dame M, Srinivas S, Costantini F, Mendelsohn C. 2001. Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nat Genet 27:74-78.
4. Brownlee NA, Perkins LA, Stewart W, Jackle B, Pettenati MJ, Koty PP, Iskandar SS, Garvin AJ. 2007. Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney. Arch Pathol Lab Med 131:446-451.
5. Cheng HT, Kim M, Valerius MT, Surendran K, Schuster-Gossler K, Gossler A, McMahon AP, Kopan R. 2007. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 134:801-811.
6. Cutcliffe C, Kersey D, Huang CC, Zeng Y, Walterhouse D, Perlman EJ. 2005. Clear cell sarcoma of the kidney: Up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res 11:7986-7994.
7. Douglass EC, Wilimas JA, Green AA, Look AT. 1985. Abnormalities of chromosomes 1 and 11 in Wilms' tumor. Cancer Genet Cytogenet 14:331-338.
8. Dressler GR. 2009. Advances in early kidney specification, development and patterning. Development 136:3863-3874.
9. Faa G, Gerosa C, Fanni D, Monga G, Zaffanello M, Van Eyken P, Fanos V. 2012. Morphogenesis and molecular mechanisms involved in human kidney development. J Cell Physiol 227:1257-1268.
10. Gadd S, Beezhold P, Jennings L, George D, Leuer K, Huang CC, Huff V, Tognon C, Sorensen PH, Triche T, Coffin CM, Perlman EJ. 2012. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: A Children's Oncology Group study. J Pathol 228:119-130.
11. Grieshammer U, Cebrian C, Ilagan R, Meyers E, Herzlinger D, Martin GR. 2005. FGF8 is required for cell survival at distinct stages of nephrogenesis and for regulation of gene expression in nascent nephrons. Development 132:3847-3857.
12. Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM. 2005. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23:7312-7321.
13. Hatini V, Huh SO, Herzlinger D, Soares VC, Lai E. 1996. Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev 10:1467-1478.
14. Hendry C, Rumballe B, Moritz K, Little MH. 2011. Defining and redefining the nephron progenitor population. Pediatr Nephrol 26:1395-1406.
15. Hing S, Lu YJ, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M, Shipley J, Pritchard-Jones K. 2001. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 158:393-398.
16. James RG, Kamei CN, Wang Q, Jiang R, Schultheiss TM. 2006. Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells. Development 133:2995-3004.
17. Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J. 1991. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res 51:5937-5942.
18. Kobayashi A, Valerius MT, Mugford JW, Carroll TJ, Self M, Oliver G, McMahon AP. 2008. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 3:169-181.
19. Levinson RS, Batourina E, Choi C, Vorontchikhina M, Kitajewski J, Mendelsohn CL. 2005. Foxd1-dependent signals control cellularity in the renal capsule, a structure required for normal renal development. Development 132:529-539.
20. Mendelsohn C, Batourina E, Fung S, Gilbert T, Dodd J. 1999. Stromal cells mediate retinoid-dependent functions essential for renal development. Development 126:1139-1148.
21. Mengelbier LH, Karlsson J, Lindgren D, Ora I, Isaksson M, Frigyesi I, Frigyesi A, Bras J, Sandstedt B, Gisselsson D. 2010. Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster. Am J Pathol 177:2609-2621.
22. Mugford JW, Sipila P, McMahon JA, McMahon AP. 2008. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol 324:88-98.
23. Mugford JW, Yu J, Kobayashi A, McMahon AP. 2009. High-resolution gene expression analysis of the developing mouse kidney defines novel cellular compartments within the nephron progenitor population. Dev Biol 333:312-323.
24. O'Meara E, Stack D, Lee CH, Garvin AJ, Morris T, Argani P, Han JS, Karlsson J, Gisselson D, Leuschner I, Gessler M, Graf N, Fletcher JA, O'Sullivan MJ. 2012. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney. J Pathol 227:72-80.
25. Punnett HH, Halligan GE, Zaeri N, Karmazin N. 1989. Translocation 10;17 in clear cell sarcoma of the kidney. A first report. Cancer Genet Cytogenet 41:123-128.
26. Rakheja D, Weinberg AG, Tomlinson GE, Partridge K, Schneider NR. 2004. Translocation (10;17)(q22;p13): a recurring translocation in clear cell sarcoma of kidney. Cancer Genet Cytogenet 154:175-179.
27. Rivera MN, Haber DA. 2005. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5:699-712.
28. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374-378.
29. Schuster AE, Schneider DT, Fritsch MK, Grundy P, Perlman EJ. 2003. Genetic and genetic expression analyses of clear cell sarcoma of the kidney. Lab Invest 83:1293-1299.
30. Seibel NL, Li S, Breslow NE, Beckwith JB, Green DM, Haase GM, Ritchey ML, Thomas PR, Grundy PE, Finklestein JZ, Kim T, Shochat SJ, Kelalis PP, D'Angio GJ. 2004. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. J Clin Oncol 22:468-473.
31. Self M, Lagutin OV, Bowling B, Hendrix J, Cai Y, Dressler GR, Oliver G. 2006. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J 25:5214-5228.
32. Sheng WW, Soukup S, Bove K, Gotwals B, Lampkin B. 1990. Chromosome analysis of 31 Wilms' tumors. Cancer Res 50:2786-2793.
33. Vandesompele J, De Paepe A, Speleman F. 2002. Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal Biochem 303:95-98.
34. Wang Q, Lan Y, Cho ES, Maltby KM, Jiang R. 2005. Odd-skipped related 1 (Odd 1) is an essential regulator of heart and urogenital development. Dev Biol 288:582-594.